Federal Register of Legislation - Australian Government

Primary content

PB 34 of 2022 Other as made
This instrument amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 to add, delete and alter listed pharmaceutical items and associated periods and circumstances.
Administered by: Health
Registered 29 Apr 2022
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 34 of 2022

 

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022
(No. 4)

 

National Health Act 1953

 

I, CAROLINE TURNOUR, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated               28 April 2022

 

 

 

 

 

 

 

 

 

CAROLINE TURNOUR

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

 

 


Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Pharmaceutical benefits—early supply) Instrument 2015
(PB 120 of 2015).
                                                                                                                                   2

 


1        Name

(1)          This instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2022 (No. 4).

(2)          This Instrument may also be cited as PB 34 of 2022.

2        Commencement

(1)          Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

1 May 2022

1 May 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)          Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3        Authority

This instrument is made under subsection 84AAA(2) of the National Health Act 1953.

4        Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

[1]        Schedule 1, after entry for Anastrozole

insert:

Apalutamide

Tablet 60 mg

20

120

5

 

[2]        Schedule 1, after entry for Buprenorphine in the form Injection (modified release) 128 mg in 0.36 mL pre‑filled syringe

insert:

 

Injection (modified release) 160 mg in 0.45 mL pre-filled syringe

20

1

0

 

[3]        Schedule 1, omit entry for Risdiplam

[4]        Schedule 1, after entry for Varenicline in the form Tablet 1 mg (as tartrate)

insert:

 

Tablet 1 mg (as tartrate) (s19A)

20

56

2

 

 

 

20

112

0